Saibal Mukhopadhyay Selected Research

Saibal Mukhopadhyay Research Topics

Disease

6	Cardiovascular Diseases (Cardiovascular Disease) 05/2022 - 11/2020
3	Thrombosis (Thrombus) 11/2021 - 05/2011
2	Hypercholesterolemia 05/2022 - 03/2020
2	Acute Coronary Syndrome 05/2022 - 03/2020
2	COVID-19 03/2022 - 07/2021
2	ST Elevation Myocardial Infarction 03/2022 - 12/2018
2	Mitral Valve Stenosis (Mitral Stenosis) 09/2021 - 03/2018
2	Rheumatic Heart Disease (Rheumatic Heart Diseases) 09/2021 - 01/2014
2	Ventricular Tachycardia 07/2021 - 03/2012
2	Dyslipidemias (Dyslipidemia) 11/2020 - 05/2018
2	Pathologic Constriction (Stenosis) 05/2014 - 05/2004
2	Eisenmenger Complex (Eisenmenger's Syndrome) 09/2011 - 10/2006
2	Cardiac Tamponade 09/2005 - 07/2004
2	Fistula 03/2004 - 05/2003
1	Autonomic Nervous System Diseases (Dysautonomia) 03/2022
1	Orthostatic Hypotension (Postural Hypotension) 03/2022
1	Postural Orthostatic Tachycardia Syndrome 03/2022
1	Stroke (Strokes) 01/2022
1	Ischemic Stroke 01/2022
1	Mitral Valve Insufficiency (Mitral Regurgitation) 09/2021
1	Hyperthyroidism 07/2021
1	Inflammation (Inflammations) 09/2020
1	Homozygous Familial Hypercholesterolemia 03/2020
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 03/2020
1	Hypertension (High Blood Pressure) 05/2018
1	Vitamin D Deficiency 03/2018
1	Hemorrhage 01/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2014
1	Aortic Rupture 05/2014
1	Heart Failure 03/2013
1	Torsades de Pointes (Torsade de Pointes) 03/2012
1	Familial Primary Pulmonary Hypertension 10/2006
1	Body Weight (Weight, Body) 10/2006
1	Congenital Abnormalities (Deformity) 01/2005
1	Rupture 05/2004
1	Atrial Heart Septal Defects (Atrial Septal Defect) 03/2004
1	Aortic Coarctation 11/2003

Drug/Important Bio-Agent (IBA)

5	LipidsIBA 05/2022 - 03/2020
4	LDL CholesterolIBA 05/2022 - 03/2020
3	oxidized low density lipoproteinIBA 05/2022 - 03/2020
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022 - 01/2022
2	fibrin fragment D (D-dimer)IBA 09/2021 - 09/2020
2	HDL CholesterolIBA 11/2020 - 03/2020
2	Fibrinogen (Factor I)FDA Link 09/2020 - 05/2018
2	Tadalafil (Cialis)FDA Link 09/2011 - 10/2006
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 09/2011 - 10/2006
1	hydroxide ionIBA 03/2022
1	CholesterolIBA 03/2022
1	SmokeIBA 11/2021
1	Troponin T (Troponin T1)IBA 07/2021
1	Triglycerides (Triacylglycerol)IBA 11/2020
1	InterleukinsIBA 09/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2020
1	Interleukin-6 (Interleukin 6)IBA 09/2020
1	Monoclonal AntibodiesIBA 03/2020
1	Proprotein Convertase 9IBA 03/2020
1	Uric Acid (Urate)IBA 05/2018
1	C-Reactive ProteinIBA 05/2018
1	HomocysteineIBA 05/2018
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2018
1	Immunologic Factors (Immunomodulators)IBA 03/2018
1	25-hydroxyvitamin DIBA 03/2018
1	Lipoprotein(a)IBA 05/2014
1	alpha-2-HS-GlycoproteinIBA 01/2014
1	Pharmaceutical PreparationsIBA 03/2013
1	Atropine FDA LinkGeneric 03/2012
1	Lidocaine (Xylocaine)FDA LinkGeneric 03/2012
1	MagnesiumIBA 03/2012
1	Phenytoin (Dilantin)FDA LinkGeneric 03/2012
1	Amiodarone (Amiodarona)FDA LinkGeneric 03/2012
1	Protamines (Protamine Sulfate)FDA Link 05/2011
1	CyanoacrylatesIBA 07/2004
1	Coenzyme A (CoA)IBA 11/2003

Therapy/Procedure

5	Stents 01/2016 - 11/2003
4	Therapeutics 05/2022 - 03/2013
3	Septal Occluder Device 01/2005 - 03/2004
2	Secondary Prevention 11/2020 - 03/2020
2	Transjugular Intrahepatic Portasystemic Shunt 03/2004 - 05/2003
1	Thrombolytic Therapy 01/2022
1	Electric Countershock (Cardioversion) 07/2021
1	Percutaneous Coronary Intervention 12/2018
1	Cardiac Resynchronization Therapy 03/2013
1	Drug-Eluting Stents 05/2011
1	Punctures 09/2005